Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of member benefits, join or renew today.
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Salim Hayek, MD, a cardiovascular specialist in cardio-oncology from the UTMB Health is joined by Amelia Langston, MD, a hematology and medical oncology specialist from Emory University to discuss their new AHA scientific statement on the cardiovascular management of patients undergoing hematopoietic stem cell transplantation (HSCT). They review the phases of HCST, the incidence of cardiovascular complications, long-term management, and the significance of survivorship post-transplant.
Recommended Videos
Treating Patients in the Cardiac Cath Lab who've had Out of Hospital Cardi...
Cardiac Cath Lab Assessment of Comatose Patient with an Out of Hospital Ca...
Effectiveness of ECRP in Cath Lab Mgmt of Comatose Patient with Out of Hos...
Cardiac Cath Lab Management of Comatose NSTEMI Patients with an Out of Hos...
Key Takeaways and Limitations in Large-Core Ischemic Stroke Endovascular T...
Loading...
Save Video
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.